Rhesus macaque antibody molecules: Sequences and heterogeneity of alpha and gamma constant regions

Immunology

Volumn 111, Issue 1, 2004, Pages 66-74

  Scinicariello, Franco ^a   Engleman, Carrie N ^b   Jayashankar, Lakshmi ^b   McClure, Harold M ^c   Attanasio, Roberta ^b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d 402 Kell Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MESSENGER RNA; RHESUS ANTIBODY;

ALLELE; ALLOTYPE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN GENE; INTRASPECIFIC VARIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CHINA; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; INDIA; MACACA MULATTA; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

EID: 0347126490     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01767.x     Document Type: Article

References (36)

1. Kennedy RC, Shearer MH, Hildebrand W. Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine 1997; 15:903-8.
2. Hansen LM, Solnick JV. Selection for urease activity during Helicobacter pylori infection of rhesus macaques (Macaca mulatta). Infect Immun 2001; 69:3519-22.
3. Attanasio R, Pehler K, McClure HM. Immunogenicity and safety of Mycobacterium tuberculosis culture filtrate proteins in non-human primates. Clin Exp Immunol 2000; 119:84-91.
4. Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 2002; 76:1932-43.
5. Hahn CS, French OG, Foley P, Martin EN, Taylor RP. Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J Immunol 2001; 166:1057-65.
6. Tongren JE, Yang C, Collins WE, Sullivan JS, Lal AA, Xiao L. Expression of proinflammatory cytokines in four regions of the brain in Macaca mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg 2002; 62:530-4.
7. Hirsch VM, Lifson JD. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 2000; 49:437-77.
8. Johnson WE, Lifson JD, Lang SM, Johnson RP, Desrosiers RC. Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus. J Virol 2003; 77:375-81.
9. Shibata R, Igarashi T, Haigwood N et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999; 5:204-10.
10. Nishimura Y, Igarashi T, Haigwood N, Sadjadpour R, Plishka RJ, Buckler-White A, Shibata R, Martin MA. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002; 76:2123-30.
11. Ferrantelli F, Hofmann-Lehmann R, Rasmussen RA et al. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. AIDS 2003; 1:30-9.
12. Nezlin R. General characteristics of immunoglobulin molecules. In: Nezlin R, ed. The Immunoglobulins: Structure and Function 1st edn. San Diego: Academic Press, 1998:3-73.
13. Bengten E, Wilson M, Miller N, Clem LW, Pilstrom L, Warr GW. Immunoglobulin isotypes: structure, function, and genetics. Curr Top Microbiol Immunol 2000; 248:189-219.
14. Kerr MA. The structure and function of human IgA. Biochem J 1990; 271:285-96.
15. Lefranc M-P, Lefranc G. The Immunoglobulin Factsbook. San Diego: Academic Press, 2001.
16. Martin LN. Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using DEAE cellulose and protein-A sepharose. J Immunol Methods 1982; 50:319-29.
17. Calvas P, Apoil P, Fortenfant F, Roubinet F, Andris J, Capra D, Blancher A. Characterization of the three immunoglobulin G subclasses of macaques. Scand J Immunol 1999; 49:595-610.
18. Scinicariello F, Attanasio R. Intraspecies heterogeneity of immunoglobulin alpha-chain constant region genes in rhesus macaques. Immunology 2001; 103:441-8.
19. Sumiyama K, Saitou N, Ueda S. Adaptive evolution of the IgA hinge region in primates. Mol Biol Evol 2002; 19:1093-9.
20. Attanasio R, Jayshankar L, Engleman CN, Scinicariello F. Baboon immunoglobulin constant region heavy chains: identification of four IGHG genes. Immunogenetics 2002; 54:556-61.
21. Lefranc MP. IMGT, the international ImMunoGeneTics database. Nucl Acids Res 2003; 31:307-10.
22. Huck S, Fort P, Crawford DH, Lefranc MP, Lefranc G. Sequence of human gamma 3 heavy chain constant region: comparison with the other human C genes. Nucl Acids Res 1986; 14:1779-89.
23. Dard P, Huck S, Frippiat JP, Lefranc G, Langaney A, Lefranc MP, Sanchez-Mazas A. The IGHG3 gene shows a structural polymorphism characterized by different hinge lengths: sequence of a new 2-exon hinge gene. Hum Genet 1997; 99:138-41.
24. Trichel AM, Rajakumar PA, Murphey-Corb M. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol 2002; 31:171-8.
25. Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA. SIV (mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 2002; 16:1489-96.
26. Bensmana M, Huck S, Lefranc G, Lefranc M-P. The human immunoglobulin pseudo-gamma IGHGP gene shows no major structural defect. Nucl Acids Res 1988; 16:3108.
27. Radaev S, Sun PD. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors. J Biol Chem 2001; 276:16478-83.
28. Roux KH, Strelets L, Michaelsen TE. Flexibility of human IgG subclasses. J Immunol 1997; 159:3372-82.
29. Scharf O, Golding H, King LR, Eller N, Frazier D, Golding B, Scott DE. Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol 2001; 75: 6558-65.
30. Xu Y, Oomen R, Klein MH. Residue at position 331 in the IgG1 and IgG4, CH2 domains contributes to their differential ability to bind and activate complement. J Biol Chem 1994; 269:3469-74.
31. Glamann J, Hirsch VM. Characterization of a macaque recombinant monoclonal antibody that binds to a CD4-induced epitope and neutralizes simian immunodeficiency virus. J Virol 2000; 74:7158-63.
32. Idusogie EE, Wong PY, Presta LG, Gazzano-Santoro H, Totpal K, Ultsch M, Mulkerrin MG. Engineered antibodies with increased activity to recruit complement. J Immunol 2001; 166:2571-5.
33. Shields RL, Namenuk AK, Hong K et al. High resolution mapping of the binding site of human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 2001; 276:6591-604.
34. Otting N, de Groot NG, Noort MC, Doxiadis GG, Bontrop RE. Allelic diversity of Mhc-DRB alleles in rhesus macaques. Tissue Antigens 2000; 56:58-68.
35. Doxiadis GG, Otting N, de Groot NG, Noort R, Bontrop RE. Unprecedented polymorphism of Mhc-DRB region configurations in rhesus macaques. J Immunol 2000; 164:3193-9.
36. Shum BP, Flodin LR, Muir DG et al. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol 2002; 168:240-52.